ClaimIt UP19

Published by: Obvio Health USA

Description

Welcome To ClaimIt UP19:
ClaimIt UP19 is a proprietary platform of ObvioHealth being used to manage a trial for a new COVID-19 therapeutic. ClaimIt UP19 removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.
The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.
Subject Journey
A brief introduction into the journey of a subject through the ClaimIt UP19 Clinical Trial App:
Subject Recruitment via Targeted Landing Page
• We utilize targeted social media advertising to cost effectively funnel potential subjects to the web-based trial recruitment landing page.
• The landing page contains details about the parameters of the trial, the benefits of participating, and financial compensation.
Screening Questionnaire
• Subjects that are interested in participating will complete an initial questionnaire designed to automatically screen for subjects that meet defined inclusion criteria.
• Individuals that are not eligible at this time are invited to join the ClaimIt UP19 Subject Database and receive invitations to participate in future trials.
Download ClaimIt UP19 App
• After passing the initial screening, a study team member may contact each subject to validate responses and ensure that all inclusion criteria are met.
• Subjects that meet all requirements are invited to download the ClaimIt UP19 app.
Informed Consent
• Subjects create a ClaimIt UP19 account and complete the Informed Consent process. A series of screens explains the parameters of the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
• Subjects will have the opportunity to connect with a member of the study team to ask questions prior to signing the informed consent form.
Intervention Period: Daily Tasks
• Complete Questionnaires/eCRF
o Subjects will contribute data to the study by completing questionnaires and eCRFs.
• Capture Product compliance
o Subjects can launch the mobile camera within the ClaimIt UP19 app to capture images of interactions with the product and document dosage compliance.
• Lab Visit or Online Appointment
o Subjects utilize a study calendar to keep track of their lab visits or virtual appointments with the study team.
• Online chat consultation
• Subjects can interact with the study team via secure chat.
Hide Show More...

Screenshots

ClaimIt UP19 FAQ

  • Is ClaimIt UP19 free?

    Yes, ClaimIt UP19 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is ClaimIt UP19 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does ClaimIt UP19 cost?

    ClaimIt UP19 is free.

  • What is ClaimIt UP19 revenue?

    To get estimated revenue of ClaimIt UP19 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Romania yet.
Ratings History

ClaimIt UP19 Reviews

No Reviews in Romania
App doesn't have any reviews in Romania yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

ClaimIt UP19 Installs

Last 30 days

ClaimIt UP19 Revenue

Last 30 days

ClaimIt UP19 Revenue and Downloads

Gain valuable insights into ClaimIt UP19 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Publisher
Obvio Health USA
Languages
Spanish, French, English, Japanese
Recent release
1.8 (3 years ago )
Released on
Feb 2, 2021 (4 years ago )
Last Updated
1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.